[
  {
    "info": {
      "NCT": "NCT05300048",
      "Protocol_No": "SER-ISD1-001",
      "jit": "Tempus",
      "trial_name": "Faeth (SER-ISD1-001) "
    },
    "disease": {
      "summary": "Advanced Solid Tumor | Colorectal Cancer |   Endometrial Cancer | Ovarian Clear Cell or Ovarian Endometrioid Carcinoma",
      "details": [
        {
          "code": "Clear Cell Ovarian Cancer (CCOV)",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        },
        {
          "code": "Colorectal Adenocarcinoma (COADREAD)",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        },
        {
          "code": "Endometrial Carcinoma (UCEC)",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        },
        {
          "code": "Endometrioid Ovarian Cancer (EOV)",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        },
        {
          "code": "Solid Tumors",
          "selection": "include",
          "stage": "Advanced Stage;Metastatic"
        }
      ]
    },
    "query": {
      "nct": "NCT05300048",
      "title": "Combination of Serabelisib and Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations",
      "current_status": "Recruiting",
      "status_verif_date": "August 2022",
      "last_update_date": "August 23, 2022",
      "trial_hold_status": "open",
      "sponsor": "Faeth Therapeutics",
      "brief_summary": "This study will evaluate the feasibility of optimizing the safety and tolerability of serabelisib (an investigational PI3K inhibitor) when combined with an ISD and with or without nab-paclitaxel with a goal of reducing side effects and enhancing anticancer activity.",
      "conditions": "Advanced Solid Tumor | PIK3CA Mutation | PTEN Loss of Function Mutation",
      "type": "Interventional",
      "phase": "Phase 1",
      "arm": [
        {
          "ArmID": "1",
          "cohortlabel": "Cohort 1a - Dose Modification without nab-paclitaxel",
          "drug": "Serabelisib | Other: Insulin Suppressing Diet | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "2+",
          "arm_hold_status": "close to complete enrollment",
          "biomarker": [
            {
              "cohort": "Cohort 1a - Dose Modification without nab-paclitaxel",
              "Gene": "PIK3CA",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "activating",
              "summary": "PIK3CA Mutation activating  "
            },
            {
              "cohort": "Cohort 1a - Dose Modification without nab-paclitaxel",
              "Gene": "PTEN",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Loss",
              "summary": "PTEN Mutation Loss "
            }
          ]
        },
        {
          "ArmID": "2",
          "cohortlabel": "Cohort 1b - Dose Modification with Nab-Paclitaxel",
          "drug": "Serabelisib | Other: Insulin Suppressing Diet | Nab paclitaxel",
          "arm_type": "Experimental",
          "line_of_therapy": "3+",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 1b - Dose Modification with Nab-Paclitaxel",
              "Gene": "PIK3CA",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "activating",
              "summary": "PIK3CA Mutation activating  "
            },
            {
              "cohort": "Cohort 1b - Dose Modification with Nab-Paclitaxel",
              "Gene": "PTEN",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Loss",
              "summary": "PTEN Mutation Loss "
            }
          ]
        },
        {
          "ArmID": "3",
          "cohortlabel": "Cohort 2 - Expansion Colorectal Cancer",
          "drug": "Serabelisib | Other: Insulin Suppressing Diet | NA",
          "arm_type": "Experimental",
          "line_of_therapy": "2+",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 2 - Expansion Colorectal Cancer",
              "Gene": "PIK3CA",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "activating",
              "summary": "PIK3CA Mutation activating  "
            },
            {
              "cohort": "Cohort 2 - Expansion Colorectal Cancer",
              "Gene": "PTEN",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Loss",
              "summary": "PTEN Mutation Loss "
            }
          ]
        },
        {
          "ArmID": "4",
          "cohortlabel": "Cohort 3 - Expansion Endometrial Cancer",
          "drug": "Serabelisib | Other: Insulin Suppressing Diet | Nab paclitaxel",
          "arm_type": "Experimental",
          "line_of_therapy": "3+",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 3 - Expansion Endometrial Cancer",
              "Gene": "PIK3CA",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "activating",
              "summary": "PIK3CA Mutation activating  "
            },
            {
              "cohort": "Cohort 3 - Expansion Endometrial Cancer",
              "Gene": "PTEN",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Loss",
              "summary": "PTEN Mutation Loss "
            }
          ]
        },
        {
          "ArmID": "5",
          "cohortlabel": "Cohort 4 - Expansion Ovarian Clear Cell or Ovarian Endometrioid Carcinoma",
          "drug": "Serabelisib | Other: Insulin Suppressing Diet | Nab paclitaxel",
          "arm_type": "Experimental",
          "line_of_therapy": "3+",
          "arm_hold_status": "open",
          "biomarker": [
            {
              "cohort": "Cohort 4 - Expansion Ovarian Clear Cell or Ovarian Endometrioid Carcinoma",
              "Gene": "PIK3CA",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "activating",
              "summary": "PIK3CA Mutation activating  "
            },
            {
              "cohort": "Cohort 4 - Expansion Ovarian Clear Cell or Ovarian Endometrioid Carcinoma",
              "Gene": "PTEN",
              "Gene2": "Not available",
              "Type": "Mutation",
              "Variant": "Not available",
              "Selection": "include",
              "Function": "Loss",
              "summary": "PTEN Mutation Loss "
            }
          ]
        }
      ],
      "docs": "<a href=\"https://therapies.securetempus.com/\" target=\"_blank\">Tempus<\/a>",
      "locations": "Sioux Falls SD",
      "doclastupdate": "2023-02-08",
      "min_age": "18 Years",
      "gender": "All",
      "link": "<a href=\"https://clinicaltrials.gov/ct2/show/NCT05300048\" target=\"_blank\">NCT05300048<\/a>"
    }
  }
]
